Materialise has been playing an active role in the field of Additive Manufacturing (also known as 3D Printing) since 1990. In addition to having the largest capacity of Additive Manufacturing equipment in Europe, we are also known for our innovative software solutions. We have used our experience and expertise to create a better and healthier world through our involvement in Additive Manufacturing for industrial and medical applications, and by providing bio-medical and clinical solutions such as medical image processing and surgical simulations. The advantages of Additive Manufacturing have been used by Materialise to develop unique solutions that make a world of difference for our many customers with their prototyping, production, and medical needs. These customers range from large companies in the automotive, consumer electronics, and consumables sectors; to famous hospitals, research institutes, and clinicians; to individual consumers interested in bringing their own unique creations to life through i.materialise or who want to purchase a celebrated .MGX design.
Show more
Type
Public
HQ
Leuven, BE
Founded
1990
Size (employees)
1,432 (est)
Materialise was founded in 1990 and is headquartered in Leuven, BE
Report incorrect company information

Materialise Office Locations

Materialise has an office in Leuven
Leuven, BE (HQ)
15 Technologielaan
Show all (1)
Report incorrect company information

Materialise Financials and Metrics

Materialise Financials

Materialise's revenue was reported to be €114.48 m in FY, 2016 which is a 12.2% increase from the previous period.
EUR

Revenue (FY, 2016)

114.5 m

Revenue growth (FY, 2015 - FY, 2016), %

12.2%

Market capitalization (27-Oct-2017)

717 m

Closing share price (27-Oct-2017)

15.2
Materialise's current market capitalization is $717 m.
EURFY, 2015FY, 2016

Revenue

102 m114.5 m

Revenue growth, %

12%
Show all financial metrics

Materialise Operating Metrics

Jun, 2014FY, 2014FY, 2015FY, 2016Jun, 2017

Patents Pending

180 146 166 192

3D Printers

98 112 144

Patents Issued

50 97 180 200

Trademarks Pending

20 22 20
Show all operating metrics
Report incorrect company information

Materialise News and Updates

3D Bioprinting Market Trend by Tissue printing, Tissue Creation, Surgery, Type, Analysis and Forecast to 2023

3D Bioprinting Market provide a detailed analysis, mainly based on Value Chain analysis, Porter’s Five Forces, Price analysis, and Supply Chain analysis etc. Posted via Industry Today. Follow us on Twitter @IndustryToday

3D Printing Market Analysis and Demand with Future Forecast to 2025

ReportsWeb says, 3D Printing Market growing at a high CAGR during forecast period. A newly added market research report focuses on 3D Printing industry that offers Competitor Data, market analysis and future prospects of 3D Printing. Posted via Industry Today. Follow us on Twitter @IndustryToday

3D Printing in Healthcare Market to see growth of 20% from 2017 to 2024

Some of the prominent companies operating in healthcare 3D printing market include Organovo Holding, Stratasys, 3D Systems, Reninshaw, Aspect Biosystems, Bio3D Technologies, Cyfuse Biomedical, 3Dynamics Systems, Envision TEC and Materialise. Posted via Industry Today. Follow us on Twitter @IndustryT…

The World 3D bioprinting Market Projected to Grow Rapidly By 2027 | Focus on Top Key Players Profile

Market Research Future published a Half-Cooked research report on “Global 3D bioprinting Market Research Report - Forecast to 2027” Market Analysis, Scope, Progress, Trends and Forecast to 2027. Posted via Industry Today. Follow us on Twitter @IndustryToday

Leading Industry of 3D Bioprinting Market is Estimated to grow at a CAGR of around 25-27% by the Year of 2027

Market Research Future published a half cooked research report on the Global 3D Bioprinting Market, which is estimated to grow at a CAGR of 25-27% during the forecast period 2017-2027. Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information